Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Schizophrenia

  Free Subscription


03.08.2026

2 Biol Psychiatry
4 Br J Psychiatry
2 J Clin Psychopharmacol
2 J Nerv Ment Dis
1 Pharmacopsychiatry
2 Psychol Med
7 Schizophr Res


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Biol Psychiatry

  1. GONZALEZ-PENAS J, Schnack HG, Hernandez CR, Diaz-Caneja CM, et al
    Cortical Hub Vulnerability and Molecular Signatures of Sulcal Widening in Schizophrenia.
    Biol Psychiatry. 2026 Jul 29:S0006-3223(26)01437.
    PubMed         Abstract available

  2. XUE X, Adelsheim Z, Gorczyca MT, Wei H, et al
    Mood and Psychosis Risk-Associated Genes Regulate Neuronal Circadian Rhythms Across the Transcriptome.
    Biol Psychiatry. 2026 Jul 27:S0006-3223(26)01436.
    PubMed         Abstract available


    Br J Psychiatry

  3. TEODORO TP
    Holodysphrenia and acute schizophrenia: Professor Barahona Fernandes's pioneering contribution to the nosology of acute transient psychoses - Psychiatry in history.
    Br J Psychiatry. 2026;229:252.
    PubMed        

  4. TREW A, Rodda J, Shergill SS
    The association between relapse and the outcome of schizophrenia and recurrent psychotic disorders: commentary, Trew et al - CORRIGENDUM.
    Br J Psychiatry. 2025;227:824.
    PubMed        

  5. RIUS-BONET J, Gras-Font J, Macip S
    Exploring ageing as a potential new therapeutic target for schizophrenia.
    Br J Psychiatry. 2026 Jul 27:1-3. doi: 10.1192/bjp.2026.10746.
    PubMed         Abstract available

  6. RICHARDS-BELLE A, Launders N, Hardoon S, Man KKC, et al
    Prescribing of antipsychotics for people diagnosed with severe mental illness in UK primary care 2000-2019: 20-year investigation of who receives treatment, with which agents and at what doses.
    Br J Psychiatry. 2025;226:269-277.
    PubMed         Abstract available


    J Clin Psychopharmacol

  7. TUDELLA GCN, Pereira MAOM, Klostermann AU, Gonzalez JVP, et al
    Efficacy and Safety of Alpha-Lipoic Acid as an Adjunctive Therapy in Schizophrenia: A Systematic Review and Meta-Analysis.
    J Clin Psychopharmacol. 2026 Jul 31. doi: 10.1097/JCP.0000000000002231.
    PubMed         Abstract available

  8. ABBAS N, Memon AA, Zulfiqar R, Noon AZ, et al
    Semaglutide and Other GLP-1 Agonists for Antipsychotic-Associated Metabolic Dysfunction in Schizophrenia: A Systematic Review and Meta-Analysis.
    J Clin Psychopharmacol. 2026 Jul 27. doi: 10.1097/JCP.0000000000002234.
    PubMed         Abstract available


    J Nerv Ment Dis

  9. LEE SW, Jung H, Bae Y
    Response to the Correspondence on "Risk of Schizophrenia After a Diagnosis of Epilepsy".
    J Nerv Ment Dis. 2026;214:71-73.
    PubMed        

  10. ABDEL AZIZ K, d'Almeida I, Schumacher MM, Finsterer J, et al
    Reconsidering the Association Between Epilepsy and Schizophrenia: Diagnostic Misclassification of Epilepsy-related Psychoses.
    J Nerv Ment Dis. 2026;214:69-70.
    PubMed        


    Pharmacopsychiatry

  11. MALCHOW B, Muhl PF, Belz M, Bramesfeld A, et al
    Guideline adherence in patients with long-term schizophrenia in Germany: Focus on clozapine and electroconvulsive therapy.
    Pharmacopsychiatry. 2026 Jul 30. doi: 10.1055/a-2899-9948.
    PubMed         Abstract available


    Psychol Med

  12. BELLANTI A, Volkmer S, Altinok DCA, Fritze S, et al
    Replicable subcortical alterations linked to neurological soft signs in schizophrenia spectrum disorders - CORRIGENDUM.
    Psychol Med. 2026;56:e250.
    PubMed        

  13. FROST R, O'Driscoll C, Peters E, Varese F, et al
    Symptom networks of therapy-seeking individuals with comorbid psychosis and PTSD.
    Psychol Med. 2026;56:e239.
    PubMed         Abstract available


    Schizophr Res

  14. TARRICONE I, Bettinardi O, Leuci E, Parmeggiani C, et al
    Real-world effectiveness of a multicomponent early intervention program for first episode psychosis in Emilia Romagna (Italy): Timeliness, specificity and fairness.
    Schizophr Res. 2026;296:227-234.
    PubMed         Abstract available

  15. INCHAUSTI F, Garcia-Poveda NV, Pinotti M, Fonseca-Pedrero E, et al
    Metacognition, identity, and durable recovery in adolescent early psychosis: A five-year mixed-methods follow-up.
    Schizophr Res. 2026;297:68-75.
    PubMed         Abstract available

  16. STILES BJ, Fraser MI, Gleeson JF, Alvarez-Jimenez M, et al
    Psychometric properties of the Self-Compassion Scale - Short Form in young adults with psychosis: Proceed with caution.
    Schizophr Res. 2026;297:58-67.
    PubMed         Abstract available

  17. D'AMBROSIO S, Tonoli F, Mayeli A, Smagula SF, et al
    The interplay between subjective time perspective, circadian rhythms, and social functioning in schizophrenia spectrum disorders: Insights from the DiAPASon study.
    Schizophr Res. 2026;297:46-57.
    PubMed         Abstract available

  18. JIANG C, Wang L, Zhang S, Ge X, et al
    Unnatural death in Chinese patients with schizophrenia spectrum disorder: Age distribution, sex and seasonal patterns.
    Schizophr Res. 2026;297:37-45.
    PubMed         Abstract available

  19. SUN X, Feng Y, Zhang J, Tang P, et al
    Association between depressive symptoms, CRP and metabolism-related indicators in Han Chinese patients with chronic schizophrenia.
    Schizophr Res. 2026;297:26-36.
    PubMed         Abstract available

  20. KLEIN HS, Fan RH, Ge T, Asgharnejad M, et al
    Exploratory anchor-based analyses to determine minimal clinically important differences for the Brief Assessment of Cognition in Schizophrenia and the Schizophrenia Cognition Rating Scale.
    Schizophr Res. 2026;297:17-25.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum